Activity

Filter

Cancel
Date Panel Item Activity
10 actions
Fetal anomalies v1.836 AKT2 Arina Puzriakova Tag for-review was removed from gene: AKT2.
Fetal anomalies v1.836 AKT2 Arina Puzriakova commented on gene: AKT2: The rating of this gene has been updated following NHS Genomic Medicine Service approval.
Fetal anomalies v1.835 AKT2 Arina Puzriakova Source Expert Review Green was added to AKT2.
Rating Changed from Amber List (moderate evidence) to Green List (high evidence)
Fetal anomalies v1.218 AKT2 Arina Puzriakova Publications for gene: AKT2 were set to
Fetal anomalies v1.217 AKT2 Arina Puzriakova Phenotypes for gene: AKT2 were changed from Hypoinsulinemic hypoglycemia with hemihypertrophy to Hypoinsulinemic hypoglycemia with hemihypertrophy, OMIM:240900; Hypoinsulinemic hypoglycemia and body hemihypertrophy, MONDO:0009416
Fetal anomalies v1.216 AKT2 Arina Puzriakova Classified gene: AKT2 as Amber List (moderate evidence)
Fetal anomalies v1.216 AKT2 Arina Puzriakova Added comment: Comment on list classification: New gene added by Rhiannon Mellis (GOSH). Following curation and clinical review it has been agreed that the associated phenotype is fetally-relevant and therefore this gene should be promoted to Green at the next GMS panel update (added 'for-review' tag)
Fetal anomalies v1.216 AKT2 Arina Puzriakova Gene: akt2 has been classified as Amber List (Moderate Evidence).
Fetal anomalies v1.215 AKT2 Arina Puzriakova Tag for-review tag was added to gene: AKT2.
Fetal anomalies v1.185 AKT2 Rhiannon Mellis gene: AKT2 was added
gene: AKT2 was added to Fetal anomalies. Sources: Literature
Mode of inheritance for gene: AKT2 was set to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
Phenotypes for gene: AKT2 were set to Hypoinsulinemic hypoglycemia with hemihypertrophy
Review for gene: AKT2 was set to GREEN
Added comment: This gene and phenotype were reviewed during meetings at Great Ormond Street hospital in October 2020. This gene has a Green evidence rating on at least one other PanelApp panel (BWS and Overgrowth panel). Clinical review and curation was performed by Lyn Chitty, Rhiannon Mellis, and Richard Scott. Outcome of review: Confirmed that phenotype is fetally-relevant: add to the Fetal anomalies panel as a Green gene.
Sources: Literature